8-K: Atomera Reports Q4 & FY2025 Results, MST Gains Traction
Quarterly and Annual Financial Results
Atomera Incorporated announced its fourth quarter and fiscal year 2025 financial results, highlighting technical breakthroughs and initial commercial adoption of its MST technology.
Summary
- Net loss for Q4 2025 was ($4.4) million, or ($0.14) per basic and diluted share, an improvement from ($5.6) million in Q3 2025 and ($4.7) million in Q4 2024.
- Fiscal year 2025 revenue was $65,000, a decrease from $135,000 in fiscal 2024.
- Fiscal year 2025 net loss was ($20.2) million, or ($0.65) per basic and diluted share, compared to ($18.4) million, or ($0.68) per basic and diluted share in fiscal 2024.
- Adjusted EBITDA loss for Q4 2025 was ($3.3) million, an improvement from ($4.4) million in Q3 2025 and ($3.9) million in Q4 2024.
- Adjusted EBITDA loss for fiscal 2025 was ($16.1) million, compared to ($15.4) million in fiscal 2024.
- Cash, cash equivalents, and short-term investments totaled $19.2 million as of December 31, 2025, down from $26.8 million as of December 31, 2024.
- Achieved a technical breakthrough demonstrating manufacturability of Mears Silicon Technology (MST) on Gate-All-Around (GAA) structures.
- Secured a first commercial customer running wafers on Gallium Nitride (GaN) with MST.
- A GaN-on-Silicon concept paper advanced to the proposal phase in the Power America funding program.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a mixed filing. While technical progress and customer engagement are positive, the continued significant net losses and declining annual revenue indicate ongoing financial challenges for this early-stage company.
Positives
- Net loss improved quarter-over-quarter, with Q4 2025 net loss of ($4.4) million compared to ($5.6) million in Q3 2025.
- Adjusted EBITDA loss also improved quarter-over-quarter, with Q4 2025 loss of ($3.3) million compared to ($4.4) million in Q3 2025.
- Achieved a technical breakthrough demonstrating MST manufacturability on Gate-All-Around (GAA) structures.
- Secured a first commercial customer running wafers on Gallium Nitride (GaN) with MST.
- GaN-on-Silicon concept paper advanced to the proposal phase in the Power America funding program.
- Fiscal year 2025 net loss per share improved to ($0.65) from ($0.68) in fiscal 2024, despite a higher total net loss.
Negatives
- Fiscal year 2025 revenue declined significantly to $65,000 from $135,000 in fiscal 2024.
- Continued to incur significant net losses, with a fiscal year 2025 net loss of ($20.2) million.
- Adjusted EBITDA loss for fiscal 2025 increased to ($16.1) million from ($15.4) million in fiscal 2024.
- Cash, cash equivalents, and short-term investments decreased to $19.2 million as of December 31, 2025, from $26.8 million as of December 31, 2024, indicating a cash burn of $7.6 million over the year.
Risks
- Only minimal engineering services and licensing revenues have been recognized to date, subjecting the company to risks inherent in an early-stage enterprise.
- Risk that licensees or Joint Development Agreement (JDA) customers may not advance to royalty-based manufacturing and distribution licenses.
- Ability to add other licensees and/or JDA customers.
- Ability to raise sufficient capital, as and when needed, to pursue further development, licensing, and commercialization of MST technology.
- Ability to protect proprietary technology, trade secrets, and know-how.
Future Outlook
The company's safe harbor statement indicates forward-looking statements regarding the prospects for the semiconductor industry and MST technology's ability to significantly improve semiconductor performance. Management commentary suggests high demand for Atomera's innovations in bleeding-edge transistors and new materials for next-generation data centers. No specific financial guidance is provided.
Management Comments
- "The results we are seeing with MST for GAA transistors are inspiring and together with our OEM partner we are presenting groundbreaking results to some of the most demanding customers in the industry."
- "We also have a top 20 semiconductor company running wafers on GaN, demonstrating industry pull for the innovative work that, up to now, we have done in university and government labs."
- "From bleeding edge transistors to enabling new materials to run next generation data centers, Atomera is providing innovations that are in high demand for todays markets."
Industry Context
StockSavvy.ai notes that Atomera's focus on Mears Silicon Technology (MST) for Gate-All-Around (GAA) transistors and Gallium Nitride (GaN) applications positions it within critical growth areas of the semiconductor industry. GAA is a key architecture for advanced nodes, while GaN is crucial for power electronics and high-frequency applications, both driven by demand for higher performance and power efficiency in data centers and next-generation devices. The company's progress with a "top 20 semiconductor company" and a Power America funding program proposal indicates increasing industry validation for its proprietary technology.
Comparison to Industry Standards
- No specific comparable companies, projects, or results are mentioned in the filing to allow for a direct comparison to global benchmarks.
Stakeholder Impact
- Shareholders: Experience continued dilution (shares outstanding increased) and significant net losses, leading to a decrease in cash reserves. However, technical breakthroughs and initial commercial traction offer potential long-term upside.
- Customers: Benefit from MST technology's potential to improve semiconductor performance and power efficiency in advanced transistors (GAA) and new materials (GaN).
- Employees: Continued investment in Research & Development (R&D) supports ongoing innovation and job stability in technical roles.
Next Steps
- Conduct an earnings call and distribute an investor presentation on February 12, 2026, at 2:00 p.m. PT (5:00 p.m. ET).
- Continue to pursue the further development, licensing, and commercialization of MST technology.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Fiscal year end and Q4 2024 end; cash, cash equivalents and short-term investments balance of $26.8 million. |
| 2025-12-31 | Fiscal year end and Q4 2025 end; cash, cash equivalents and short-term investments balance of $19.2 million. |
| 2026-02-12 | Date of report, press release issuance, and investor webinar/earnings call. |
Recommendation
holdThe company is in an early stage with promising technical breakthroughs and initial commercial customer engagement, particularly in critical areas like GAA and GaN. However, it continues to incur significant net losses and burn cash, with declining annual revenue. The long-term potential is high if MST gains widespread adoption, but the financial performance indicates substantial risks. A "hold" recommendation reflects the balance between the speculative upside from technology validation and the ongoing financial challenges and execution risks.
Keywords
semiconductor, MST, Mears Silicon Technology, Gate-All-Around, GAA, GaN, Gallium Nitride, licensing, semiconductor materials, power efficiency, transistor enhancement, advanced nodes, RF-SOI, DRAM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.